Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases

References

• Brown RS. Autoimmune thyroid disease: unlocking a complex puzzle. Curr Opin Pediatr. 2009;21(4):523–528.
   PubMed Web of Science ®Google Scholar
• Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves’ disease, and thyroid-associated ophthalmopathy. Thyroid. 2008;18(9):953–958.
   PubMed Web of Science ®Google Scholar
• Phenekos C, Vryonidou A, Gritzapis AD, et al. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto’s thyroiditis (Th1) and Graves’ disease (Th2). Neuroimmunomodulation. 2004;11(4):209–213.
   PubMed Web of Science ®Google Scholar
• Lin JD, Wang YH, Fang WF, et al. Serum BAFF and thyroid autoantibodies in autoimmune thyroid disease. Clin Chim Acta. 2016;462:96–102.
   PubMed Web of Science ®Google Scholar
• Wakelkamp IM, Gerding MN, Van Der Meer JW, et al. Both Th1- and Th2-derived cytokines in serum are elevated in Graves’ ophthalmopathy. Clin Exp Immunol. 2000;121(3):453–457.
   PubMed Web of Science ®Google Scholar
• Salvi M, Pedrazzoni M, Girasole G, et al. Serum concentrations of proinflammatory cytokines in Graves’ disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol. 2000;143:197–202.
   PubMed Web of Science ®Google Scholar
• Tamaru M, Matsuura B, Onji M. Increased levels of serum interleukin-12 in Graves’ disease. Eur J Endocrinol. 1999;141:111–116.
   PubMed Web of Science ®Google Scholar
• Miyauchi S, Matsuura B, Onji M. Increased levels of serum interleukin-18 in Graves’ disease. Thyroid. 2000;10(9):815–819.
   PubMed Web of Science ®Google Scholar
• Mikos H, Mikos M, Rabska-Pietrzak B, et al. The clinical role of serum concentrations of selected cytokines: IL-1beta, TNF-alpha and IL-6 in diagnosis of autoimmune thyroid disease (AITD) in children. Autoimmunity. 2014;47(7):466–472.
   PubMed Web of Science ®Google Scholar
• Senturk T, Kozaci LD, Kok F, et al. Proinflammatory cytokine levels in hyperthyroidism. Clin Invest Med. 2003;26:58–63.
   PubMed Web of Science ®Google Scholar
• Alnaqdy A, Al-Maskari M. Levels of cytokines and thyroid autoantibodies in Omani patients with Graves’ disease. Br J Biomed Sci. 2007;64(4):164–167.
   PubMed Web of Science ®Google Scholar
• Kokkotou E, Marafelia P, Mantzos EI, et al. Serum monocyte chemoattractant protein-1 is increased in chronic autoimmune thyroiditis. Metabolism. 2002;51(11):1489–1493.
   PubMed Web of Science ®Google Scholar
• Kemp EH, Metcalfe RA, Smith KA, et al. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol. 2003;59(2):207–213.
   PubMed Web of Science ®Google Scholar
• Hiratsuka I, Itoh M, Yamada H, et al. Simultaneous measurement of serum chemokines in autoimmune thyroid diseases: possible role of IP-10 in the inflammatory response. Endocr J. 2015;62(12):1059–1066.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Fallahi P, Rotondi M, et al. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves’ disease, and modulation by methimazole therapy and thyroidectomy. Br J Surg. 2006;93(10):1226–1231.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18(1):4–25.
   PubMed Web of Science ®Google Scholar
• Iitaka M, Noh JY, Kitahama S, et al. Elevated serum granulocyte colony-stimulating factor levels in patients with Graves’ disease. Clin Endocrinol. 1998;48(3):275–280.
   PubMed Web of Science ®Google Scholar
• Ye X, Liu J, Wang Y, et al. Increased serum VEGF and b-FGF in Graves’ ophthalmopathy. Graefes Arch Clin Exp Ophthalmol. 2014;252(10):1639–1644.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tang J, Hu Q, et al. A preliminary study on the expression and clinical value of platelet-derived growth factor BB, hypoxia inducible factor-1alpha and C-C motif chemokine receptor-2 in peripheral blood during the pathogenesis of Graves’ disease. Endokrynologia Polska. 2018;69(1):9–15.
   PubMed Web of Science ®Google Scholar
• Lin JD, Wang YH, Liu CH, et al. Association of IRF8 gene polymorphisms with autoimmune thyroid disease. Eur J Clin Invest. 2015;45(7):711–719.
   PubMed Web of Science ®Google Scholar
• Simera I, Moher D, Hoey J, et al. A catalogue of reporting guidelines for health research. Eur J Clin Invest. 2010;40(1):35–53.
   PubMed Web of Science ®Google Scholar
• Sanders J, Oda Y, Roberts S, et al. The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor. J Clin Endocrinol Metab. 1999;84(10):3797–3802.
   PubMed Web of Science ®Google Scholar
• Ajjan RA, Weetman AP. Cytokines in thyroid autoimmunity. Autoimmunity. 2003;36(6–7):351–359.
   PubMed Web of Science ®Google Scholar
• Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun. 2010;34(3):J322–J326.
   PubMed Web of Science ®Google Scholar
• Al-Humaidi MA. Serum cytokines levels in Graves’ disease. Saudi Med J. 2000;21:639–644.
   PubMed Web of Science ®Google Scholar
• Shen J, Li Z, Li W, et al. Th1, Th2, and Th17 cytokine involvement in thyroid associated ophthalmopathy. Dis Markers. 2015;2015:1–6.
   Google Scholar
• Esfahanian F, Ghelich R, Rashidian H, et al. Increased levels of serum interleukin-17 in patients with Hashimoto’s thyroiditis. Indian J Endocr Metab. 2017;21(4):551–554.
   PubMedGoogle Scholar
• Hidaka Y, Okumura M, Shimaoka Y, et al. Increased serum concentration of interleukin-5 in patients with Graves’ disease and Hashimoto’s thyroiditis. Thyroid. 1998;8(3):235–239.
   PubMed Web of Science ®Google Scholar
• Vannucchi G, Covelli D, Curro N, et al. Serum BAFF concentrations in patients with Graves’ disease and orbitopathy before and after immunosuppressive therapy. J Clin Endocrinol Metab. 2012;97(5):E755–759.
   PubMed Web of Science ®Google Scholar
• Turner MD, Nedjai B, Hurst T, et al. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta. 2014;1843(11):2563–2582.
   PubMed Web of Science ®Google Scholar
• Gupta S. Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules. Exp Gerontol. 2002;37(2–3):293–299.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Itoh M, Okamura T, et al. Relative levels of the inflammatory cytokine TNFalpha and the soluble CD40 ligand profile in serum correlate with the thyrotoxic activity of Graves’ disease. Thyroid. 2012;22(5):516–521.
   PubMed Web of Science ®Google Scholar
• Sato K, Satoh T, Shizume K, et al. Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture. J Clin Endocrinol Metab. 1990;70(6):1735–1743.
   PubMed Web of Science ®Google Scholar
• Ajjan RA, Watson PF, Weetman AP. Cytokines and thyroid function. Adv Neuroimmunol. 1996;6(4):359–386.
   PubMedGoogle Scholar
• Diny NL, Rose NR, Čiháková D. Eosinophils in autoimmune diseases. Front Immunol. 2017;8:484.
   PubMed Web of Science ®Google Scholar